Bioniz Therapeutics
Irvine
About Bioniz Therapeutics
Bioniz is an emerging biotechnology/drug development company focused on discovering small peptides and molecules for the treatment of autoimmune diseases and some forms of cancer. Bioniz mission is to complete proof of concept and preclinical studies of its lead technology and seek partners to conduct clinical trials for regulatory approval and commercialization. At Bioniz, they are committed to the discovery of novel molecules that enhance the lives of people across the globe. They perform our research with integrity and conscious, and bear in mind always our responsibility to the public health and their investors. It was founded in 2009 and headquartered in Irvine, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.3M
- Funding stage: M&A
- Last round: Series A (Aug 2016)
- Website: bioniz.com
- Phone: (949)273-6000
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/bioniz-therapeutics-29234 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.